Luo J - Search Results

1

Targeting protein kinases benefits cancer immunotherapy.

Zhang Z, Bu L, Luo J, Guo J. Zhang Z, et al. Among authors: luo j. Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188738. doi: 10.1016/j.bbcan.2022.188738. Epub 2022 Jun 2. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35660645 Review.

2

Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis.

Zhang MX, Zhang LZ, Fu LM, Yao HH, Tan L, Feng ZH, Li JY, Lu J, Pan YH, Shu GN, Li PJ, Tang YM, Liao ZY, Wei JH, Chen W, Guo JP, Luo JH, Chen ZH. Zhang MX, et al. Among authors: luo jh. Oncogene. 2021 Sep;40(37):5639-5650. doi: 10.1038/s41388-021-01971-7. Epub 2021 Jul 28. Oncogene. 2021. PMID: 34321604 Free PMC article.

3

Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy.

Pan YH, Zhang JX, Chen X, Liu F, Cao JZ, Chen Y, Chen W, Luo JH. Pan YH, et al. Front Immunol. 2021 Aug 4;12:643282. doi: 10.3389/fimmu.2021.643282. eCollection 2021. Front Immunol. 2021. PMID: 34421886 Free PMC article.

4

TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types.

Cao JZ, Yao GS, Liu F, Tang YM, Li PJ, Feng ZH, Luo JH, Wei JH. Cao JZ, et al. Aging (Albany NY). 2022 Mar 27;14(6):2868-2879. doi: 10.18632/aging.203980. Epub 2022 Mar 27. Aging (Albany NY). 2022. PMID: 35344507 Free PMC article.

5

A deep learning model and human-machine fusion for prediction of EBV-associated gastric cancer from histopathology.

Zheng X, Wang R, Zhang X, Sun Y, Zhang H, Zhao Z, Zheng Y, Luo J, Zhang J, Wu H, Huang D, Zhu W, Chen J, Cao Q, Zeng H, Luo R, Li P, Lan L, Yun J, Xie D, Zheng WS, Luo J, Cai M. Zheng X, et al. Among authors: luo r, luo j. Nat Commun. 2022 May 19;13(1):2790. doi: 10.1038/s41467-022-30459-5. Nat Commun. 2022. PMID: 35589792 Free PMC article.

6

Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.

Gui CP, Chen YH, Zhao HW, Cao JZ, Liu TJ, Xiong SW, Yu YF, Liao B, Cao Y, Li JY, Huang KB, Han H, Zhang ZL, Chen WF, Jiang ZY, Gao Y, Han GP, Tang Q, Ouyang K, Qu GM, Wu JT, Guo JP, Li CX, Li PX, Liu ZP, Hsieh JT, Cai MY, Li XS, Wei JH, Luo JH. Gui CP, et al. Lancet Digit Health. 2023 Aug;5(8):e515-e524. doi: 10.1016/S2589-7500(23)00095-X. Epub 2023 Jun 29. Lancet Digit Health. 2023. PMID: 37393162 Free article.

7

Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape.

Gui C, Wei J, Mo C, Liang Y, Cen J, Chen Y, Wang D, Luo J. Gui C, et al. Among authors: luo j. Int J Biol Sci. 2023 Jul 31;19(12):3951-3969. doi: 10.7150/ijbs.85209. eCollection 2023. Int J Biol Sci. 2023. PMID: 37564213 Free PMC article.

8

Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8⁺ T cell infiltration and functional transition.

Yu A, Hu J, Fu L, Huang G, Deng D, Zhang M, Wang Y, Shu G, Jing L, Li H, Chen X, Yang T, Wei J, Chen Z, Zu X, Luo J. Yu A, et al. Among authors: luo j. J Immunother Cancer. 2023 Oct;11(10):e007230. doi: 10.1136/jitc-2023-007230. J Immunother Cancer. 2023. PMID: 37802603 Free PMC article.

9

Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo.

Chen Z, Yu T, Zhou B, Wei J, Fang Y, Lu J, Guo L, Chen W, Liu ZP, Luo J. Chen Z, et al. Among authors: luo j. Biomaterials. 2016 Mar;81:125-134. doi: 10.1016/j.biomaterials.2015.11.022. Epub 2015 Nov 12. Biomaterials. 2016. PMID: 26731576

10

A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis.

Liao K, Deng S, Xu L, Pan W, Yang S, Zheng F, Wu X, Hu H, Liu Z, Luo J, Zhang R, Kuang DM, Dong J, Wu Y, Zhang H, Zhou P, Bei JX, Xu Y, Ji Y, Wang P, Ju HQ, Xu RH, Li B. Liao K, et al. Among authors: luo j. Cancer Res. 2020 Feb 15;80(4):675-688. doi: 10.1158/0008-5472.CAN-19-2060. Epub 2020 Jan 16. Cancer Res. 2020. PMID: 31948940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,465 results

Search Page